Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer

BACKGROUND: Neoadjuvant chemoradiation therapy (CRT) is a widely used preoperative treatment strategy for locally advanced rectal cancer (LARC). However, a few studies have evaluated the molecular changes caused by neoadjuvant CRT in these cancer tissues. Here, we aimed to investigate changes in imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Incheol, Lee, Hye Won, Byun, Sang Jun, Park, Jee Young, Min, Hyeonji, Lee, Sung Hwan, Lee, Ju-Seog, Kim, Shin, Bae, Sung Uk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949478/
https://www.ncbi.nlm.nih.gov/pubmed/33692216
http://dx.doi.org/10.1136/jitc-2020-001610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949478/
https://www.ncbi.nlm.nih.gov/pubmed/33692216
http://dx.doi.org/10.1136/jitc-2020-001610

Ejemplares similares